KLOW Results: what changed in each study

What these results can tell you

KLOW results come from four separate sets of studies, one for each peptide. Researchers haven’t compared the four-part blend with one part, fewer parts, or a control group.

A result for one peptide isn’t a KLOW result. Each section starts with the strongest finding and then gives its limits.

The studies are real, but the test of all four together hasn’t happened. I'd keep that gap beside every claim about the blend.

Ask who or what was studied and what changed. Then ask whether the result could matter to you.

For your visit, ask how the limits apply to you. Your clinician can say what it can’t prove.

What KPV changed in gut studies

A 2008 study ^[3] found that KPV calmed signs of swelling in human gut cells in a dish. The paper’s lab signs numbered 6 and 8 also fell. In mice, KPV in drinking water made colitis less severe.

The dish used 10 nanomoles per liter. The mouse water used 100 micromoles per liter; both are lab amounts, not human doses.

Sore gut cells pulled KPV through a doorway in the cell wall. A dish test measured about 160 micromoles per liter passing through, but that number says nothing about KLOW in a person.

In 2024, KPV was paired with FK506, a drug that calms the immune system ^[8]. Tiny drops carried both to the guts of mice with short-term and long-term colitis.

Together, they repaired the gut lining and eased swelling more than either drug alone. A 2010 mouse study ^[9] had tested an older way to carry medicine to the colon.

This work supports more KPV research. It doesn’t show that the KLOW blend treats colitis.

I'd ask whether any human bowel study supports the claim you heard. These papers don’t include you.

Your question about the bowel work deserves a clear answer. Don’t leave until you know what remains unproved.

What GHK-Cu changed in skin and bowel studies

GHK-Cu has the most human skin work among the four ingredients. A 2015 review ^[4] found more collagen in 70% of women given GHK-Cu.

The rates were 50% with vitamin C and 40% with retinoic acid. Collagen is the firm protein that helps support skin.

The studies also found changes in loose skin, fine lines, and wrinkle depth against placebo, which means a look-alike skin treatment. Blood GHK fell from about 200 nanograms per milliliter at age 20 to about 80 nanograms per milliliter by age 60.

A 2018 dish study ^[5] used 1–10 nanomoles per liter, a tiny lab amount. About 31.2% of cell instructions changed by 50%-or-greater, meaning by half or more.

In one group, 41 instructions became more active. Other changes involved DNA repair and defense from cell damage.

A 2025 animal study found less bowel damage with GHK-Cu ^[11]. A 2025 review covered skin use and trouble getting GHK-Cu through skin ^[12].

A mouse study also found more hair growth ^[15]. I'd ask which result a clinic expects you to notice and whether people were tested.

You can bring the skin work up with your clinician. Ask what it means for you and what it can’t settle.

What BPC-157 changed in tendon studies

A 2003 rat study ^[2] tested BPC-157 after fully cutting the Achilles tendon. The rats received 10 micrograms, 10 nanograms, or 10 picograms.

BPC-157 improved tendon strength, use, and appearance. Another BPC-157 check found better tissue under a microscope.

BPC-157 also helped tendon cells grow in a dish. A 2006 follow-up ^[10] found better healing where tendon meets bone and less harm from a steroid.

A 2025 safety test gave two healthy adults 10 mg on day one and 20 mg on day two ^[6]. Neither had a reported bad event or clear change in safety blood tests.

Two people are far too few to prove safety or benefit. A 2026 review ^[7] gathered past work on pain and tissue repair, mostly in animals.

If your Achilles tendon or knee hurts, ask how the study injury compares with yours. I'd also ask what proof comes from people.

For your visit, ask how the tendon work applies to you. Your clinician can say what it can’t prove.

What studies of the full TB-500 parent protein found

A 1999 rat study ^[1] tested the full protein, thymosin beta-4, from which the short piece is cut. Skin closed 42% more at 4 days and as much as 61% more at 7 days than with salt water.

Just 10 picograms made skin cells move 2–3-fold, or two to three times as far in a dish. The TB-500 parent study found the rat wounds also shrank at least 11% more by day 7.

A 2024 animal study found less lung scarring after animals breathed in the full protein ^[13]. A 2026 sports review found hopeful animal work but little sound human safety work ^[14].

The review warned of possible serious harm. It didn’t name one specific harm from these two parts; the warning rests on how little human safety work exists.

The full 43-amino-acid protein is named thymosin beta-4, meaning it has many linked building blocks. TB-500 is a short piece cut from it.

Another paper also used thymosin beta-4. Researchers didn’t test the short TB-500 piece, so you can’t assume both forms act alike.

I'd ask which form a clinic means when it says “TB-500 research.” Then ask what is known in people.

Your question about the wound work deserves a clear answer. Don’t leave until you know what remains unproved.

What the full KLOW blend still hasn’t shown

Researchers haven't tested the KPV, GHK-Cu, BPC-157 and TB-500 blend in a controlled study. There is no trial in people, animal test, or cell test comparing all four with one part, three parts, or a control liquid.

So there is no result for the full KLOW blend. Combining four studied substances in one vial doesn't prove that the mix will work.

The four may affect different steps in tissue repair, but that idea remains open. Ask anyone making a blend claim to show you a study that used the actual blend.

While you weigh the claim, ask what was seen and whether it applies to you. Your health needs more than a lab result.

You can bring the untested blend up with your clinician. Ask what it means for you and what it can’t settle.